Creating R&D Incentives for Medicines for Neglected Diseases [electronic resource] : An Economic Analysis of Parallel Imports, Patents, and Alternative Mechanisms to Stimulate Pharmaceutical Research /
Müller-Langer, Frank.author.
Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country’s perspective.
Description based upon print version of record.
Includes bibliographical references and index.
The TRIPS Agreement and Access to Patented Medicines -- Economic Analysis of Patents -- Patent Protection in the Developing World: Theory and Evidence -- Legal and Economic Analysis of Parallel Imports -- Solutions for the Problem of Underinvestment in R&D for Medicines for Neglected Infectious and Tropical Diseases -- Conclusion and Ideas for Further Research.
Virtually no research is targeted at developing medicines for tropical diseases as the expected market returns from R&D into these diseases in the private pharmaceuticals sector are too low. Frank Müller-Langer addresses the market failure with respect to R&D for medicines for tropical diseases and the lack of short-term access to affordable medicines in poor countries. The author analyzes additional push and pull mechanisms to stimulate R&D for pharmaceutical products alongside patent protection which may help mitigate the problem of those consumers in poor countries who lack access to affordable medicines. Furthermore, he reasons that a global regime of banning parallel trade from low-income countries to high-income countries is desirable from a developing country’s perspective.
Health economics.
Management.
Industrial management.
Health Economics.
Innovation/Technology Management.